Atherectomy Devices Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034
Page: 215 | Report Code: LS250116 | Research Suite: Report (PDF) & Market Data (Excel)
Atherectomy is a medical procedure that is designed to
remove plaque from arteries, found in both coronary and peripheral vascular
systems. Plaque accumulation, which causes atherosclerosis, is capable of
constricting or blocking blood vessels, resulting in diseases including
coronary artery disease (CAD) and peripheral artery disease (PAD). The main purpose
of these device is to remove these plaques to restore normal blood flow.
MARKET
OVERVIEW
The atherectomy devices market is valued at approximately USD 969.52 million in 2023 and is projected to reach USD 2325.88 million by 2034 exhibiting a compound annual growth rate (CAGR) of 8.28% during the forecast period of 2024-2034. The primary objective of atherectomy devices is to efficiently remove or ablate the plaques while maintaining the structural integrity of the surrounding artery tissue. The devices use various techniques like cutting, shaving, sanding, or vaporizing plaque to restore normal blood flow through the damaged vessels.
GROWTH
DRIVERS
The rising prevalence of coronary artery disease and
peripheral artery disease is one of the primary factors propelling the market
for atherectomy devices. According to the National Institute of Health (NIH),
lower extremity peripheral artery disease affected approximately 8.5 million
people in the US and around 230 million worldwide in 2021, indicating an
increasing demand for efficient treatment solutions. The rising prevalence of
these diseases is associated with lifestyle factors including obesity and
inactivity, which further increases the requirement for atherectomy procedures.
There is a noticeable shift towards minimally invasive
surgeries due to their associated benefits, such as reduced trauma, quicker
recovery times, and lower risk of complications compared to traditional open
surgery. Atherectomy procedures are acknowledged for their minimally invasive
nature, which makes them more appealing to both patients and healthcare
providers; thus, driving its market demand.
MARKET
SEGMENTATION:
By Type
-
·
Directional Atherectomy
·
Rotational Atherectomy
·
Orbital Atherectomy
·
Laser Atherectomy
By Application
-
·
Peripheral Vascular Applications
·
Cardiovascular Applications
·
Neurovascular Applications
By End User
-
·
Hospitals and Surgical Centers
·
Ambulatory Care Centers
·
Other End Users
By
Region -
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Atherectomy
Devices Market By Type Segment Review:
In directional atherectomy, a catheter with a rotating blade is used to cut away plaque in a specific direction. This technique enables the precise removal of plaque while also preserving the surrounding healthy tissue. The adoption of directional atherectomy in clinical practice is encouraged by the increasing awareness among healthcare professionals about its benefits over traditional methods. The need for efficient treatment alternatives like directed atherectomy are becoming increasingly popular due to the rising incidence of PAD, due to factors such as diabetes, obesity, and an aging population.
Atherectomy
Devices Market By Application Segment Review:
The use of atherectomy devices market is becoming
increasingly prevalent for peripheral vascular applications, particularly for
the treatment of PAD, a common circulatory condition where narrowed arteries
reduce blood flow to the limbs. The market for atherectomy devices is
substantially expanding due to the rising incidence of peripheral arterial
disease. Millions of people worldwide suffer from PAD, which has increased need
for efficient treatment solutions. The market growth is further fueled by the
aging population's susceptibility to vascular diseases.
Atherectomy
Devices Market By End User Segment Review:
Hospitals and surgical centers are primary users of
atherectomy devices because of their extensive capabilities in treating
cardiovascular disorders. Interventions like atherectomy are necessary to
reduce plaque buildup in arteries caused by CVDs, which include peripheral
artery disease and coronary artery disease. According to the NIH, CVDs
accounted for 20.5 million deaths in 2021 worldwide. The need for efficient
treatment options for this expanding patient population is driving up the
adoption of atherectomy devices in hospitals and surgical centers.
There is a significant increase in the use of minimally
invasive surgical techniques among healthcare providers and patients. This
trend is driving hospitals to incorporate atherectomy devices into their
standard treatment protocols.
Atherectomy
Devices Market By Region Segment Review:
The market exhibits significant regional variations, with North
America leading the market in 2024 due to the high prevalence of cardiovascular
diseases, such as coronary artery disease and peripheral artery disease, and
the presence of leading manufacturers in the region.
Atherectomy
Devices Market Regional Synopsis:
The market in North America is anticipated to dominate the
global market for atherectomy devices market due to high prevalence rates of
cardiovascular diseases, favorable reimbursement policies, growing acceptance
and adoption of atherectomy systems among medical professionals, and ongoing
clinical trials.
Europe is another crucial player in this market, driven by growing
geriatric population, rising incidence rates of cardiovascular diseases, and
regulatory support.
The Asia Pacific is expected to grow at the highest CAGR
during the forecast period due to increasing patient population suffering from
cardiovascular conditions, improving healthcare infrastructure, and rising
awareness about minimally invasive surgical options among patient and
professionals.
In Latin America, the market is gradually expanding due to
rising healthcare investments and growing awareness for advanced treatment
options for cardiovascular diseases.
The market in the Middle East and Africa is witnessing growth potential due to the increasing prevalence of cardiovascular diseases necessitating advanced treatment options, rising urbanization, and advancement in healthcare infrastructures.
Atherectomy
Devices Market Key Challenges:
The high cost associated with this medical equipment is one
of the most primary challenges in the market for atherectomy devices. The cost
involved in developing, manufacturing, and regulatory approval of atherectomy
devices are significant, which often becomes expensive for healthcare providers
and patients. For example, cutting-edge technology like lasers and orbital
atherectomy devices are usually more costly than traditional methods, which
makes them less accessible in certain healthcare settings, especially in
developing nations. These gadgets' high cost is likely to hinder its adoption
among hospitals and clinics with limited funding or resources.
The regulatory framework for medical devices is becoming
increasingly stringent in many regions worldwide. Manufacturers of atherectomy
devices are required to navigate complicated approval processes that vary
significantly by country, which often delay product launches and increase costs
substantially. For instance, for obtaining FDA approval in the United States,
it is necessary to undergo rigorous testing and documentation requirements that
sometimes take years to complete. The risk and cost associated with these
stringent regulations are expected to prevent new entrants from entering the
market or discourage innovation among existing players.
Competitive
Landscape:
The global market for atherectomy devices is characterized
by a diverse range of established players and emerging firms, each striving to
enhance their market presence through various strategies such as innovation
through technology advancement, strategic partnerships for enhanced product
development and distribution channels, strict adherence to regulatory
standards, effective communication about minimally invasive benefits, and
global expansion efforts.
Companies are investing significantly in research and
development (R&D) to innovate and enhance their product offerings. This
includes developing more sophisticated devices that improve efficacy and safety.
This focus in innovation not only enhances patient outcomes but also boosts the
acceptance rate among healthcare professionals.
Key
Players:
·
Boston Scientific Corporation
·
Cardiovascular Systems, Inc.
·
Avinger
·
Koninklijke Philips N.V.
·
Becton, Dickinson and Company
·
Abbott
·
Cordis
·
Biomerics LLC
· Other Key & Niche Players